Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
4.320
-0.120 (-2.70%)
At close: Apr 28, 2026, 4:00 PM EDT
4.270
-0.050 (-1.16%)
After-hours: Apr 28, 2026, 4:04 PM EDT
Camp4 Therapeutics Market Cap
Camp4 Therapeutics has a market cap or net worth of $224.29 million as of April 28, 2026. Its market cap has increased by 430.18% in one year.
Market Cap
224.29M
Enterprise Value
118.33M
1-Year Change
430.18%
Ranking
Category
Stock Price
$4.32
Market Cap Chart
Since the IPO on October 11, 2024, Camp4 Therapeutics's market cap has increased from $208.55M to $224.29M, an increase of 7.55%. That is a compound annual growth rate of 4.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 230.52M | -27.52% |
| Dec 31, 2025 | 318.03M | 202.65% |
| Dec 31, 2024 | 105.08M | -49.61% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adagene | 243.81M |
| Orchestra BioMed Holdings | 241.69M |
| Codexis | 238.08M |
| Fennec Pharmaceuticals | 235.81M |
| Nuvectis Pharma | 235.78M |
| Milestone Pharmaceuticals | 231.81M |
| Polaryx Therapeutics | 229.61M |
| Keros Therapeutics | 226.95M |